--- title: "13:42 ETSHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--FSRL, SYNA, TECH, and NDRA" type: "News" locale: "en" url: "https://longbridge.com/en/news/291575243.md" description: "Monteverde & Associates PC is investigating potential class action lawsuits regarding mergers involving First Reliance Bancshares (FSRL), Synaptics (SYNA), Bio-Techne (TECH), and ENDRA Life Sciences (NDRA). The firm, recognized for recovering millions for shareholders, invites investors to review proposed transaction terms and contact them for free information." datetime: "2026-07-02T17:42:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291575243.md) - [en](https://longbridge.com/en/news/291575243.md) - [zh-HK](https://longbridge.com/zh-HK/news/291575243.md) --- # 13:42 ETSHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--FSRL, SYNA, TECH, and NDRA , /PRNewswire/ -- **Class Action Attorney** Juan Monteverde **with** Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a **Top 50** **Firm** in the 2025 ISS Securities Class Action Services Report. We are headquartered at the **Empire State Building** in New York City and are investigating - **First Reliance Bancshares, Inc. (OTCQX:** **FSRL****)** related to its sale to Colony Bankshares, Inc. Under the terms of the proposed transaction, First Reliance shareholders will receive either (i) $19.75 in cash or 0.94 of a share of Colony's common stock in exchange for each share of First Reliance common stock. **Click here for more info** **https://monteverdelaw.com/case/first-reliance-bancshares-inc/****.** **It is free and there is no cost or obligation to you.** - **Synaptics Incorporated (NASDAQ:** **SYNA****)** related to its sale to onsemi. Under the terms of the proposed transaction, Synaptics shareholders will receive 1.350 shares of onsemi's common stock for each Synaptics share. **Click here for more information** **https://monteverdelaw.com/case/synaptics-incorporated/****. It is free and there is no cost or obligation to you.** - **Bio-Techne Corporation (NASDAQ:** **TECH****)** related to its sale to Merck KGaA. Under the terms of the proposed transaction, Bio-Techne shareholders are expected to receive $73.00 per share in cash. **Click here for more information** **https://monteverdelaw.com/case/bio-techne-corporation/****. It is free and there is no cost or obligation to you.** - **ENDRA Life Sciences Inc. (NASDAQ:** **NDRA****)** related to its merger with Noble Africa LLC. Upon closing of the proposed transaction, ENDRA shareholders are expected to own approximately 3% of the combined company. **Click here for more info** **https://monteverdelaw.com/case/endra-life-sciences-inc/****.** **It is free and there is no cost or obligation to you.** **NOT ALL LAW FIRMS ARE THE SAME.** Before you hire a law firm, you should talk to a lawyer and ask: 1. Do you file class actions and go to Court? 2. When was the last time you recovered money for shareholders? 3. What cases did you recover money in and how much? **About Monteverde & Associates PC** Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. **No company, director or officer is above the law.** If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our **website** or contact Juan Monteverde, Esq. either via e-mail at **\[email protected\]** or by telephone at (212) 971-1341. Contact: Juan Monteverde, Esq. MONTEVERDE & ASSOCIATES PC **The Empire State Building** 350 Fifth Ave. Suite 4740 New York, NY 10118 United States of America \[email protected\] Tel: (212) 971-1341 Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. SOURCE Monteverde & Associates PC ### Related Stocks - [SYNA.US](https://longbridge.com/en/quote/SYNA.US.md) - [TECH.US](https://longbridge.com/en/quote/TECH.US.md) - [NDRA.US](https://longbridge.com/en/quote/NDRA.US.md) - [CBAN.US](https://longbridge.com/en/quote/CBAN.US.md) - [ON.US](https://longbridge.com/en/quote/ON.US.md) - [MRK.DE](https://longbridge.com/en/quote/MRK.DE.md) - [MKKGY.US](https://longbridge.com/en/quote/MKKGY.US.md) - [29273B500.US](https://longbridge.com/en/quote/29273B500.US.md) ## Related News & Research - [Bio-Techne Q4 revenue rises 3%, beats estimates](https://longbridge.com/en/news/295650922.md) - [ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger](https://longbridge.com/en/news/296103378.md) - [Is Synaptics (SYNA) Undervalued On Earnings Growth Despite A Wider Loss?](https://longbridge.com/en/news/296099789.md) - [Cirrus Logic Sees Mixed-Signal Growth Pipeline Despite PC and Supply Chain Headwinds](https://longbridge.com/en/news/295736718.md) - [Bio-Techne declares Q3 2026 distribution of R$ 0.01 per unit, payable Sept. 3](https://longbridge.com/en/news/295953690.md)